Cargando…

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile dermatomyositis

Detalles Bibliográficos
Autores principales:	Enders, Felicitas Bellutti, Bader-Meunier, Brigitte, Baildam, Eileen, Constantin, Tamas, Dolezalova, Pavla, Feldman, Brian, Lahdenne, Pekka, Magnusson, Bo, Nistala, Kiran, Pilkington, Clarissa, Ravelli, Angelo, Russo, Ricardo, van Brussel, Marco, van der Net, JanJaap, Wedderburn, Lucy, Vastert, Bas, Wulffraat, Nico, McCann, Liza, van Royen-Kerkhof, Annet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184348/ http://dx.doi.org/10.1186/1546-0096-12-S1-P89

Ejemplares similares

Consensus-based recommendations for the management of juvenile dermatomyositis
por: Enders, Felicitas Bellutti, et al.
Publicado: (2017)

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of the antiphospholipid syndrome
por: Groot, Noortje, et al.
Publicado: (2014)

SHARE – workpackage 5 : evidence based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus
por: Groot, Noortje, et al.
Publicado: (2014)

SHARE – workpackage 5: evidence-based recommendations for diagnosis and treatment of kawasaki disease and henoch schönlein purpura
por: de Graeff, Nienke, et al.
Publicado: (2014)

SHARE – workpackage 5: development of best practices of diagnosis and treatment for paediatric rheumatic diseases throughout Europe
por: Vastert, Sebastiaan, et al.
Publicado: (2014)

Share – Workpackage 4: addressing the need for health care for paediatric rheumatic diseases throughout europe
por: Dolezalova, Pavla, et al.
Publicado: (2014)

Share – Workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile idiopathic arthritis
por: Vastert, Sebastiaan, et al.
Publicado: (2014)

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis
por: Culpo, Roberta, et al.
Publicado: (2014)

SHARE – workpackage 5: evidence-based recommendations for diagnosis and treatment of rare paediatric vasculitides
por: de Graeff, Nienke, et al.
Publicado: (2014)

PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
por: Bellutti Enders, F, et al.
Publicado: (2013)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools
por: Wienke, Judith, et al.
Publicado: (2018)

Design of the muscles in motion study: a randomized controlled trial to evaluate the efficacy and feasibility of an individually tailored home-based exercise training program for children and adolescents with juvenile dermatomyositis
por: Habers, Esther A, et al.
Publicado: (2012)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Increased Presence of FOXP3(+) Regulatory T Cells in Inflamed Muscle of Patients with Active Juvenile Dermatomyositis Compared to Peripheral Blood
por: Vercoulen, Yvonne, et al.
Publicado: (2014)

TS-MME Workpackages
por: Vuillemin, V
Publicado: (2006)

Anti–Cytosolic 5′‐Nucleotidase 1A Autoantibodies Are Absent in Juvenile Dermatomyositis
por: Rietveld, Anke, et al.
Publicado: (2021)

Clinically inactive disease in juvenile dermatomyositis – a proposed revision to the printo criteria
por: Almeida, Beverley, et al.
Publicado: (2014)

Galectin‐9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation
por: Wienke, Judith, et al.
Publicado: (2019)

Beam Dynamics Workpackage Sessions Summary
por: Schulte, Daniel
Publicado: (2004)

CD4(+)FOXP3(+) regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis
por: Vercoulen, Yvonne, et al.
Publicado: (2011)

CD4(+)FOXP3(+) regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis
por: Vercoulen, Yvonne, et al.
Publicado: (2011)

Comparison of the utility and validity of three scoring tools to detect skin disease in patients with juvenile dermatomyositis
por: Campanilho-Marques, Raquel, et al.
Publicado: (2014)

Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis
por: Boom, V., et al.
Publicado: (2015)

The PRINTO provisional definition of remission in juvenile dermatomyositis
por: Lazarevic, D, et al.
Publicado: (2011)

Proposal for the development of an international minimal data collection for juvenile dermatomyositis (JDM)
por: McCann, Liza J, et al.
Publicado: (2011)

Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response
por: Lerkvaleekul, Butsabong, et al.
Publicado: (2021)

Results from the ELAN-BDYN Workpackage in 2004
por: Schulte, Daniel
Publicado: (2005)

JIA rehabilitation in 2014 and beyond: - a collaborative effort between child, family and health professional
por: Van Der Net, Janjaap
Publicado: (2014)

Regulatory B cell Il-10 production is diminished in juvenile dermatomyositis
por: Piper, Christopher, et al.
Publicado: (2014)

Exercise limitation in juvenile onset Mixed Connective Tissue Disease (MCTD)
por: Net, JJ van der, et al.
Publicado: (2008)

PReS-FINAL-1020: Dysregulation of the peripheral blood D cell compartment is associated with disease activity in juvenile dermatomyositis
por: Piper, C, et al.
Publicado: (2013)

Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research
por: McCann, Liza J, et al.
Publicado: (2018)

Improving the Translational Medicine Process: Moving Patients From “End-Users” to “Engaged Collaborators”
por: Battaglia, Manuela, et al.
Publicado: (2019)

Driving Medical Innovation Through Interdisciplinarity: Unique Opportunities and Challenges
por: Gohar, Faekah, et al.
Publicado: (2019)

Developing a provisional, international Minimal Dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research
por: McCann, Liza J, et al.
Publicado: (2014)

Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use
por: McCann, Liza J., et al.
Publicado: (2015)

Longitudinal Motor-Developmental Outcomes in Infants with a Critical Congenital Heart Defect
por: Sprong, Maaike C. A., et al.
Publicado: (2022)

Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis
por: Nistala, Kiran, et al.
Publicado: (2013)

Comparison of Children With Onset of Juvenile Dermatomyositis Symptoms Before or After Their Fifth Birthday in a UK and Ireland Juvenile Dermatomyositis Cohort Study
por: Martin, N, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jcia8bj313fta00kqr798fi863